Reversible restrictive cardiomyopathy secondary to chloroquine [2];Miocardiopatía restrictiva reversible secundaria a cloroquina

Medicina Clinica

Volumn 129, Issue 4, 2007, Pages 157-

  Jiménez, Verónica Hernández ^a   Falero, Jesús Saavedra ^a   Navas, Rafael ^b  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE;

ADULT; CARDIOMEGALY; CARDIOTOXICITY; CASE REPORT; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HUMAN; LETTER; LUNG CONGESTION; MALE; RESTRICTIVE CARDIOMYOPATHY; RHEUMATOID ARTHRITIS;

EID: 34548614003     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13107491     Document Type: Letter

References (6)

1. Texeira RA. Cardiac damage from chronic use of chloroquine. A case report and review of the literature. Arq Bras Cardiol. 2002;79:85-8.
2. Baquet JP. Chloroquine cardiomyopathy with conduction disorders. Heart. 1999;81:221-3.
3. Ross JM. Choloroquine cardiotoxicity: clinicopathologic features in three patients and comparison with three patients with Fabry disease. Cardiovas Pathol. 2002;11:277-83.
4. Nord JE. Hidroxichloroquine cardiotoxicity in systemic lupus erythematosus: a report case of 2 cases and review of the literature. Semin Arthritis Rheum. 2004;33:336-51.
5. Morand EF. Continuation of long-term treatment with hydroxocloroquine in systemic lupus erythematosus and rheumatoid arthritis. Am Rheum Dis. 1992;51:1318-21.
6. Anderson RJ. Hydroxichloroquine therapy in rheumatic diseases. Bull Rheum Dis. 1996;44:6-8.